跳至主要内容
临床试验/NCT00362492
NCT00362492已完成4 期

9-10 Days Versus Prolonged Thromboprophylaxis in Patients Without Evidence of Ultrasound Proximal Thromboembolism After Total Knee Joint Replacement: a Randomized Controlled Trial

University Hospital, Caen32 个研究点 分布在 1 个国家目标入组 850 人开始时间: 2004年6月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
850
试验地点
32
主要终点
Thromboembolism occuring between day 7-35 ;

研究概览

简要总结

The purpose of this study is to determine whether stopping Low Molecular Weight Heparin (LMWH) thromboprophylaxis is safe after total knee joint replacement. The investigators select patients without proximal thromboembolism assessed by bilateral venous ultrasound examination 7-10 days after surgery. the investigators hypothesis is that stopping thromboprophylaxis is equally effective than prolonging thromboprophylaxis in order to prevent post-surgery complications in this population.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
46 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • First total knee joint replacement
  • Signed informed consent
  • Non-inclusion Criteria:
  • History of venous thromboembolism/major bleeding/Heparin induced thrombopenia
  • Active cancer
  • Long-term anticoagulation

排除标准

  • 未提供

结局指标

主要结局

Thromboembolism occuring between day 7-35 ;

Major bleeding occuring between day 7-35 ;

LMWH induced thrombopenia

All cause mortality

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (32)

Loading locations...

相似试验